Taiwan Semiconductor
TSM
Micron Technology
MU
NVIDIA
NVDA
4
Advanced Micro Devices
AMD
5
Adobe
ADBE
US Stock MarketDetailed Quotes
PHVS Pharvaris
- 15.460
- -0.620-3.86%
Close Mar 20 16:00 ET
- 15.460
- 0.0000.00%
Pre 06:21 ET
838.44MMarket Cap-5.48P/E (TTM)
16.255High15.400Low19.74KVolume16.000Open16.080Pre Close312.66KTurnover0.10%Turnover RatioLossP/E (Static)54.23MShares25.50052wk High2.60P/B296.12MFloat Cap14.14052wk Low--Dividend TTM19.15MShs Float42.860Historical High--Div YieldTTM5.32%Amplitude1.770Historical Low15.842Avg Price1Lot Size
About Pharvaris Company
Pharvaris NV is a clinical-stage company, which engages in bringing oral bradykinin B2-receptor antagonists to patients. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Johannes Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
Company Profile
SymbolPHVS
Company NamePharvaris
Listing DateFeb 5, 2021
Issue Price20.00
Founded2015
CEOMr. Berndt Modig
MarketNASDAQ
Employees82
Fiscal Year Ends12-31
AddressEmmy Noetherweg 2
CityLeiden
ProvinceZuid-Holland
CountryNetherlands (the)
Zip Code2333 BK
Phone31-71-203-64-10
Websitehttp://www.pharvaris.com
Company Executives
- Name
- Position
- Salary
- Berndt Modig
- Chief Executive Officer and Executive Director
- 935.28K
- Dr. Wim Souverijns, PhD
- Chief Community Engagement and Commercial Officer
- --
- Dr. Stefan Abele, PhD
- Chief Technical Operations Officer
- --
- Dr. Peng Lu, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Anne Lesage, PhD
- Chief Early Development Officer
- --
- Annick Deschoolmeester
- Chief Human Resources Officer
- --
- Dr. Morgan Conn, PhD
- Chief Business Officer
- --
- Joan Schmidt
- Chief Legal Officer
- --
- Anna Nijdam, M.Sc.
- Head of Strategic Finance and Principal Accounting Officer
- --
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 45.00K
- Viviane Monges
- Independent Director
- 62.50K
- Hans Schikan, Pharm.D.
- Independent Director
- 61.00K
- Dr. Robert Glassman, M.D.
- Independent Director
- 50.50K
- Dr. David P. Meeker,M.D.
- Independent Director
- 94.00K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call